Phase 2 Myeloid Sarcoma Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Acute Myeloid LeukemiaMixed Phenotype Acute LeukemiaRefractory Acute Myeloid Leukemia+10 more

University of Washington62 enrolled1 locationNCT04797767

Recruiting

Phase 2

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Acute Myeloid LeukemiaMyeloproliferative NeoplasmBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+4 more

M.D. Anderson Cancer Center100 enrolled1 locationNCT03589729

Recruiting

Phase 2

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Acute Myeloid LeukemiaMyeloid Sarcoma

Ruijin Hospital48 enrolled1 locationNCT07028086